Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

NCT: NCT07089576 · RECRUITING

NCT IDNCT07089576
StatusRECRUITING
Start Date2025-11-04
Completion2032-07

Brief Summary

The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.

Frequently Asked Questions

What is Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA?

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA is a clinical trial registered under NCT07089576. Current status: RECRUITING.

What is the status of NCT07089576?

The current status of NCT07089576 (Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA) is: RECRUITING.

When did Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA start?

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA started on 2025-11-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑